We report for the first time that the JAK2 inhibitor SAR317461 clearly inhibited STAT3 phosphorylation and had substantial activity against cells (IC50 1–10 μM) from 6 of 7 different patient GSC derived GBM tumorsphere lines and three immortalized GBM lines. The gene discussed is JAK2; the disease is glioblastoma.